Coaching Tip

MARCH 15, 2011

Nothing has ever been able to keep it down for long, and nothing ever will, if we are patient and allow our economy the time to heal itself through the virtues of the free-market system. . All it takes is the desire to be innovative and creative in tackling a problem. Deregulation. Entrepreneurship.

Pharmaceuticals 84

Pharmaceuticals Creativity Long-term Power 84

Strategy Driven

MARCH 18, 2011

In The Essential Advantage : How to Win with a Capabilities-Driven Strategy , Booz & Company’s Paul Leinwand and Cesare Mainardi maintain that success in any market accrues to firms with a coherence premium – a tight match between their strategic direction and the capabilities that make them unique. Let’s go after it.”

Resources 52

Resources Industry System Strategy 52

Harvard Business Review

OCTOBER 29, 2012

If the cost of innovation is falling, that should enable more of it from poorer countries, companies or cooperatives. If it's not, the already big and already rich will dominate innovation. Some of this may just be the product of the high regulatory costs in pharmaceuticals, but research by Harvard's F.M.

Cost 8

Cost Innovation Wireless Disruptive Innovation 8

Harvard Business Review

MARCH 28, 2012

The Swiss pharmaceutical giant Roche is nothing if not determined in its quest to acquire Illumina, the San Diego-based leader in genetic-sequencing equipment. An acquirer looking for innovation would have been likelier to try to buy Gateway, a company that is almost an after-thought now. billion tender offer directly to shareholders.

Innovation 13

Innovation Company Biotechnology CFO 13

Harvard Business Review

SEPTEMBER 14, 2011

We recently visited the brand-new R&D lab of Dr Reddy's , one of India's leading pharmaceutical firms. Dr Reddy's plan is to leverage Chirotech's scientific capabilities to optimize drug development processes, thus lowering manufacturing costs and speeding time-to-market. Cambridge, U.K. facility in Cambridge Science Park.

Globalization 9

Globalization Innovation Decentralization Chemicals 9

Harvard Business Review

MARCH 18, 2018

Why the Pharmaceutical Industry Is Booming in Japan. Japan already enjoys the world’s second-biggest market in medical devices. percent of the 2014 global medical device market—behind the U.S. Philips, the Dutch electronics and health care corporation, is among the foreign companies attracted to Japan’s market.

Health Care 8

Health Care Industry Pharmaceuticals Content 8

Harvard Business Review

MAY 7, 2015

The convergence of mobile, analytics, context-rich systems, and the cloud, together with an explosion of information, is transforming sales, and enabling buyers and salespeople to engage with each other in more effective and efficient ways. Context rich systems. Cloud Computing and 5.

Trends 8

Trends Technology Pharmaceuticals Team 8

Harvard Business Review

OCTOBER 26, 2017

“The medieval guild system was a primitive networking exercise.” “He that will not apply new remedies must expect new evils; for time is the greatest innovator,” stated Francis Bacon. The major innovation lay in an extraordinary machine already in use in Lucca, about 150 kilometers southwest of Bologna.

Education 8

Education Pharmaceuticals Innovation Industry 8

Harvard Business Review

AUGUST 14, 2018

However, they have all failed in China, the world’s largest digital market. Google, for example, has succeeded in dominating many foreign markets that have radically different political systems and cultures (including Indonesia, Thailand, and Saudi Arabia). market on China. market on China.

Competitive Advantage 11

Competitive Advantage Business Model Technology Marketing 11

Harvard Business Review

JULY 4, 2017

Tim Cook recently confirmed that Apple is working on ‘autonomous systems.’ With that in mind, I can see three potential scenarios for how Apple might play in the autonomous car market. With that in mind, I can see three potential scenarios for how Apple might play in the autonomous car market.

Transportation 9

Transportation Sports Pharmaceuticals Health Care 9

Harvard Business Review

MARCH 11, 2013

Apple is probably the most successful and innovative company on earth over the past decade, and it's extremely closed and secretive. And today the company has become more open in a number of areas, as the pressures of the market forces are forcing it to open up even further. Then to your credit, you bring up the paradox yourself.

Supply Chain 15

Supply Chain Open-book Software Niche Marketing 15

Harvard Business Review

APRIL 2, 2018

health care system woefully underperform relative to those made in health care in other countries. To be sure, many factors influence health outcomes and the investments the health care system makes are only one input. Yet, investments in the U.S. For instance, the U.S. For instance, the U.S.

Health Care 8

Health Care Insurance Pharmaceuticals Incentives 8

Harvard Business Review

OCTOBER 23, 2014

That’s why pharmaceutical, biotechnology, and medical device companies need to define their relevance in this new health care ecosystem, and soon. Think of it as a 360-degree/24-7 support system. They’re also sharing risk. The new business model has yet to solidify, and the leaders have yet to emerge. But not for long.

Health Care 8

Health Care Pharmaceuticals Information Technology Supply Chain 8

Harvard Business Review

JUNE 8, 2015

Pharmaceutical companies, buffeted by regulatory changes, new drug technologies that alter entry barriers and competition, price pressures, and an estimated 300,000 job cuts since 2000, seem to fit the popular narrative of large organizations unable to deal with disruptive forces.

Health Care 8

Health Care Venture Capitalist Strategic Fit Pharmaceuticals 8

Harvard Business Review

MARCH 27, 2018

political system, including the 2016 U.S. Apple and Google, for example, each control a popular mobile phone operating system platform (and key apps on that platform), Amazon controls the largest online merchant platform, and Facebook controls the largest social network platform. Nor is it likely to be the last. presidential election.”

Company 11

Company Advertising Incentives Engineering 11

Harvard Business Review

JUNE 14, 2017

And ease of access means ease of market entry: Emerging data providers can get on their feet quickly and create new sources of competition. How the most innovative providers are creating value. But as more data and more data providers flood the market, a competitive position based solely on data becomes impossible to defend.

Health Care 9

Health Care Levitt Competitive Advantage Pharmaceuticals 9

Harvard Business Review

DECEMBER 18, 2014

It used to be that hospitals and health systems operated as islands, selecting and purchasing medical supplies, devices and medications in isolation, and keeping their operational and leadership practices to themselves. Those numbers yield a very different type of supplier/customer conversation.

Health Care 8

Health Care Retail Mayo Pharmaceuticals 8

Harvard Business Review

FEBRUARY 4, 2013

How easy is it to change a flawed economic or governance system, such as our current 1.5-planets-and-counting Just under 1,000 companies account for half of the world's market capitalization, Eccles notes. The third scenario is breakthrough , where business leaders work to address problems inherent in the system.

EPS 8

EPS Innovation CEO Pharmaceuticals 8

Harvard Business Review

FEBRUARY 2, 2015

Steel did in an earlier era of manufacturing, Aquion and innovative firms like it are spearheading economic and employment growth across the country. Indeed, in a world where globalization and rapid technological changes are the norm, manufacturing, high-tech development, and innovation clearly require a different level of support.

Industry 8

Industry McKinsey Engineering Innovation 8

Harvard Business Review

OCTOBER 22, 2013

Innovation starts with new and novel ideas. When we surveyed over 300 global executives between 2008 and 2009, one of the primary concerns they expressed was their inability to compete long term without a solid innovation engine that can grow their top line. Everything, everyone, and every system evolves over time. Find Pivots.

Skills 8

Skills Power Six Sigma Disruptive Innovation 8

Harvard Business Review

JANUARY 31, 2013

First we see major shifts in demand: developing economies such as China and India are morphing from the world's source of low-cost manufacturing capacity to the world's best market opportunities. Then, manufacturing's most important role is as a driver of innovation, trade, and productivity.

Globalization 9

Globalization Supply Chain Pharmaceuticals McKinsey 9

Harvard Business Review

APRIL 16, 2012

As long as the CFO can stipulate that the company does not intend to repatriate the cash, it avoids the incremental tax that will be levied due to the territorial system of U.S. high technology or pharmaceutical) that are investing in projects with uncertain long-range payoffs. Facilitate Acquisitions. Facilitate Investments.

Company 13

Company Cost of Capital Finance Long-term 13

Harvard Business Review

OCTOBER 13, 2011

Bank marketing materials focus on the dreams, anxieties and goals of consumers. A better understanding of the drivers of behavior is needed for both banks and consumers to understand risk, and for the financial system to provide timely and targeted interventions. Risk management processes don't — but they should.

Banking 10

Banking Pharmaceuticals Microfinance Risk Management 10

Harvard Business Review

MARCH 11, 2013

Apple is probably the most successful and innovative company on earth over the past decade, and it's extremely closed and secretive. And today the company has become more open in a number of areas, as the pressures of the market forces are forcing it to open up even further. Then to your credit, you bring up the paradox yourself.

Supply Chain 8

Supply Chain Open-book Software Niche Marketing 8

Harvard Business Review

MAY 8, 2013

I recently conducted a study of 56 randomly selected companies involved in major change and innovation efforts in the high-tech, retail, pharmaceutical, banking, automotive, insurance, energy, non-profit, and health care industries. Nearly 68% of these large-scale change and innovative efforts failed.

Middle Management 8

Middle Management Management Automotive Pharmaceuticals 8

Harvard Business Review

APRIL 19, 2016

Imagine the changes afoot in the pharmaceutical, medical device, automotive, and consumer electronics industries. Innovation, customization, speed, and location are also among the opportunities it offers. What would be the cost/benefit of flattening your supply chain and moving production closer to your markets?

Supply Chain 8

Supply Chain Execution Analysis Technology 8

Harvard Business Review

APRIL 24, 2017

In addition to homing in on targeted research and development efforts, governments have a unique obligation to work with the international community, such as the World Health Organization, to ensure a common response framework is in place, particularly in fragile states, whose health systems are underdeveloped. Science/technology community.

Project 8

Project Disaggregation Globalization Comparison 8

Harvard Business Review

DECEMBER 5, 2016

Library leaders knew that given the immense changes brought on by digital innovations, as well as shifts in the communities that the Library served, it would need to evolve. Innovation communities had been used by Best Buy to grow its portion of the women’s consumer electronics market by $4.4b in less than five years.

Library 8

Library Strategy Reference Bottom-up 8

Harvard Business Review

MARCH 2, 2012

As global companies focus their strategies on developed and emerging markets, they require substantial cadres of leaders capable of operating effectively anywhere in the world. America's higher education system is a magnet for talented leaders from all over the world.

Competitive Advantage 13

Competitive Advantage Globalization Development Intellectual Capital 13

Harvard Business Review

OCTOBER 26, 2011

When biotechnology startups like Genentech began to acquire other startups to retain their edge, pharmaceutical incumbents were forced to enter the acquisition melee to remain competitive. Their behavior displays promising parallels to the early days of the biotechnology industry. Click on the table below to see at full size.).

Energy 11

Energy Finance IPO Biotechnology 11

Harvard Business Review

SEPTEMBER 5, 2016

Cigna is the first insurance company to get pharmaceutical companies to agree to value pricing based on results for certain cholesterol-lowering drugs. And providers want the flexibility to deliver outcomes in the best, most innovative, and most efficient way possible without being micromanaged by the customer. ” Health care.

Incentives 8

Incentives Health Care Education Insurance 8

Harvard Business Review

APRIL 13, 2015

Warren Buffett has earned his nickname because he’s proven time and again that he has an eye for predicting how markets will change and which companies will succeed in the aftermath. When markets or technologies change, it often requires entire segments of the value network to be reimagined. What’s changed?

Software 8

Software Trends Mass Marketing Marketing 8

Harvard Business Review

SEPTEMBER 26, 2011

Today we are mired in the Great Recession, which was brought about by the near collapse of the financial system. The stock market is short-term-oriented. Stock-based incentive compensation aligns the self-interest of management with shareholders, and a performance-based pay system increases employee motivation. I disagree.

CEO 15

CEO Short-term Long-term Restructuring 15

Harvard Business Review

SEPTEMBER 7, 2015

Hiring policies influence morale, productivity and turnover, marketing efforts shape demand growth, and competitors fight back. Strategists learn to manage and steer complex systems—without the costly risk of bankruptcy. Or what are the consequences of a conspicuous privacy scandal for a social networking company?

Seminar 8

Seminar Learning Curve Strategy Comparison 8

Harvard Business Review

SEPTEMBER 20, 2013

Content Innovation. They assume that if they collect the data, and house it in their systems, it must be their data. As one client once told me, “It’s as if I were at a farmers’ market with all the most amazing fruits and vegetables, and I can think of a hundred recipes that I would love to prepare.”

Execution 8

Execution Metrics Content Christensen 8

Harvard Business Review

SEPTEMBER 4, 2015

Innovation is widely regarded as important to long-term business performance. We’ve found that CEOs of big pharmaceutical companies, for example, are more likely to have a background as company lawyers, salespeople, or finance managers, than one in medicine or pharmaceutical R&D. Overall, it is a messy picture.

CEO 8

CEO Innovation Pharmaceuticals Merchandising 8

Harvard Business Review

FEBRUARY 26, 2018

Regeneratives are pharmaceutical cell therapy products that replace or restore cells and tissues lost to disease or aging. “To be able to do that, they need to entice companies to come to Japan, and they need to entice their own pharmaceutical companies to license in and obtain the best.” Agilis Biotherapeutics, a U.S.

Pharmaceuticals 8

Pharmaceuticals Content Licensing Trends 8